Search

Peter Tiede

Positions - Previous

PositionCompanyYearCompany's current rank
Executive DirectorSUDA Pharmaceuticals - 200992

Total Shareholder Return as at 30/04/18

1 year TSR5 year TSR
7thAdvance NanoTek1645%107%
244thGoldfields Money40%13%
628thAuctus Alternative Investments-29%0%
691stSUDA Pharmaceuticals-41%-20%
702ndMobilarm-44%-23%
721 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Revenue

92nd↓SUDA Pharmaceuticals$7.3m
97th↓Advance NanoTek$5.1m
98th↓Mobilarm$5.0m
101st↓Goldfields Money$4.2m
102nd↓Auctus Alternative Investments$4.2m
238 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer